Increasing serum complement component 1q is associated with worse prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a single-center, retrospective studyJiazhuo Tang, Bicheng Zhang, Yuxiao Song et al.|Journal of Thoracic Disease|2024Cited by 5